Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Haleon
Type | Public limited company |
---|---|
ISIN | GB00BMX86B70 |
Industry | |
Predecessor | GSK Consumer Healthcare |
Founded | 18 July 2022 (2022-07-18) |
Headquarters | Weybridge, England, UK |
Area served |
Worldwide |
Key people |
|
Products |
|
Brands | |
Revenue | £10,858 million (2022) |
£1,825 million (2022) | |
£1,119 million (2022) | |
Total assets | £34,815 million (2022) |
Total equity | £16,457 million (2022) |
Owners | |
Number of employees |
22,000+ (2022) |
Website | www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is the second largest consumer healthcare business in the world after Kenvue, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company is a global leader in over the counter medicines with a 7.3 percent market share.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.
Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.
History
GSK and Pfizer merged their consumer healthcare businesses in 2019. GSK owned just over two thirds of the joint venture, and Pfizer held the remainder.
GSK announced plans to spin-off Haleon in 2018, in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division".
Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected.Nestlé examined the possibility of a bid in conjunction with Reckitt.
A proposed $600 million spin-off of the ChapStick lip care brand was mooted in 2023.
Operations
Oral health accounted for 28.5 percent of revenue in 2021.
Gross assets amounted to over £45 billion on 31 March 2022.
Brands
Brands include:
- Abreva (Docosanol)
- Advil (Ibuprofen)
- alli (Orlistat)
- Aquafresh (oral healthcare)
- Astring-o-Sol (oral healthcare)
- Be-Total (leader in vitamins market in Italy)
- Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
- Biotene (oral healthcare)
- Boost (nutritional)
- Breathe Right (respiratory)
- Centrum (vitamins and naturals)
- Cetebe (vitamins and naturals)
- Chlorhexamed (oral healthcare)
- Cholinex (analgesics and respiratory tract)
- Citrucel (gastrointestinal)
- Coldrex (cold and flu treatment)
- Commit Lozenge (smoking cessation)
- Committed Quitters (nicotine replacement)
- Corega (oral healthcare)
- Corsodyl (oral healthcare)
- Crocin (analgesics and respiratory tract)
- Dr. Best (oral healthcare)
- ENO (gastrointestinal)
- Eumovate (dermatological)
- Fenbid (analgesics and respiratory tract)
- Flonase (fluticasone propionate)
- Formigran (analgesic/triptan)
- Grand-PA (headache/toothache/pain and fever)
- Hinds (dermatological)
- Junior Horlicks (nutritional)
- Iodex (pain relief)
- Iodosan (cold and flu treatment)
- Macleans (oral healthcare)
- Maltova (nutritional)
- Maxinutrition (nutritional)
- Med-Lemon (hot, cold and flu medication)
- Medacalm (vitamins and naturals)
- Nicorette (nicotine replacement)
- Night Nurse (cold and flu remedy)
- NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
- Odol (oral healthcare)
- Odol-med3 (oral healthcare)
- Os-cal (oral healthcare)
- Otrivin
- Panadeine (analgesics and respiratory tract)
- Panadol (analgesics and respiratory tract)
- parodontax (oral healthcare)
- Piriton/Piriteze (anti-allergy)
- Polident (oral healthcare)
- Poligrip Ultra (oral healthcare)
- Robitussin (respiratory)
- Rutinoscorbin (vitamins and naturals)
- Scott's Emulsion (vitamins and naturals)
- Sensodyne (oral healthcare)
- Shumitect (oral healthcare)
- Solpadeine (analgesics and respiratory tract)
- Super Poligrip (oral healthcare)
- Super Wernet's (oral healthcare)
- Synthol (oral healthcare)
- Theraflu (Respiratory)
- Tums (gastrointestinal)
- Viva (vitamins and naturals), origin: Nepal
- Voltaren (anti inflammatory)
- Zovirax (dermatological)
Ownership
As of 2022, Pfizer owns 32 percent of Haleon, while GSK retains a 13 percent stake.
External links
- Official website
- Business data for Haleon:
Brands | |
---|---|
People |
|
Related | |
Subsidiaries |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Predecessors, acquisitions |
|||||||||
Products |
|
||||||||
People |
|
||||||||
Litigation | |||||||||
Other | |||||||||